Cover Image

The pathophysiology, presentation and classification of Type 1 diabetes

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Kristie I. Aamodt, Alvin C. Powers
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Diabetes, Obesity and Metabolism
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Type 1 diabetes presenting in adults: Trends, diagnostic challenges and unique features
by: Carmella Evans‐Molina, et al.
Published: (2025)

Type 2 diabetes genetic risk and incident diabetes across diabetes risk enhancers
by: Filipe A. Moura, et al.
Published: (2024)

Multi‐modal models using fMRI , urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease
by: Xian Shao, et al.
Published: (2025)

Interactive online calculator for estimation of muscle and hepatic insulin sensitivity in adults with Type 1 diabetes using clinical and research biomarkers
by: Andrzej S. Januszewski, et al.
Published: (2026)

Cause‐specific death in adults with type 1 diabetes and type 2 diabetes: Insights from the UK Biobank
by: John W. Ostrominski, et al.
Published: (2024)

Increased cardiovascular risk in people with LADA in comparison to type 1 diabetes and type 2 diabetes: Findings from the DPV registry in Germany and Austria
by: Rosa C. Golomb, et al.
Published: (2024)

Type 2 diabetes, glycaemic traits, structural brain capacity and cognitive function: A Mendelian randomization analysis
by: Manjun Luo, et al.
Published: (2024)

Circulating inflammatory proteins are elevated in type 1 and type 2 diabetes and associated to complications
by: Julia I. P. van Heck, et al.
Published: (2024)

Effect of semaglutide add‐on therapy for people living with type 1 diabetes and excess weight
by: Noga C. Minsky, et al.
Published: (2025)

Prevalence of MASLD in children and adolescents with type 1 diabetes: A meta‐analysis
by: Felipe S. Moura, et al.
Published: (2024)

Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross‐sectional study from the BETTER registry
by: Thélo I. Garré, et al.
Published: (2026)

Metabolomic risk predictors of diabetic foot complications: A longitudinal observational study in type 1 diabetes
by: Jonas A. Andersen, et al.
Published: (2025)

Effects of insulin‐induced hypoglycaemia on cardiac function in people with type 1 and type 2 diabetes and people without diabetes
by: Therese Wilbek Fabricius, et al.
Published: (2025)

Nutrition interventions for anxiety, depression, stress and/or diabetes‐related distress in individuals with diabetes: A systematic review and meta‐analysis of randomised controlled trials
by: Prudence I. Morrissey, et al.
Published: (2026)

Mortality patterns in Dutch diabetes outpatients
by: Jessica C. G. Bak, et al.
Published: (2024)

Time in range—A new gold standard in type 2 diabetes research?
by: Ashni Goshrani, et al.
Published: (2025)

Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetes
by: Djordje S. Popovic, et al.
Published: (2024)

Sex as a modifier of genetic risk for type 1 diabetes
by: Hui‐Qi Qu, et al.
Published: (2025)

Impact of glucagon‐like peptide‐1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes
by: Fu‐Shun Yen, et al.
Published: (2025)

Teplizumab in Stage 2 Type 1 Diabetes: Clinical Practice Experience on Feasibility in 3 Adult Patients
by: V. Guarnotta, et al.
Published: (2026)

Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: A systematic review and meta‐analysis of randomised trials
by: Mengyun Lei, et al.
Published: (2025)

The use of an automated insulin delivery system is associated with a reduction in diabetes distress and improvement in quality of life in people with type 1 diabetes
by: Yves Reznik, et al.
Published: (2024)

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial
by: David S. Mathiesen, et al.
Published: (2025)

Incretin‐based therapy and the risk of diabetic foot ulcers and related events
by: Nikki C. C. Werkman, et al.
Published: (2024)

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non‐diabetic chronic kidney disease
by: Victor Wasehuus, et al.
Published: (2025)

Interrupting prolonged sitting reduces postprandial GIP but not GLP ‐1 responses in type 2 diabetes
by: Beth K. Logan, et al.
Published: (2025)

Accelerated onset of diabetes in non‐obese diabetic mice fed a refined high‐fat diet
by: Heidi M. Batdorf, et al.
Published: (2024)

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes
by: Ebaa Al‐Ozairi, et al.
Published: (2024)

Overweight or obesity, weight variability and the risk of retinopathy in type 1 diabetes
by: Thomas Nyström, et al.
Published: (2024)

A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus
by: Carol Wysham, et al.
Published: (2025)

Challenges in glycaemic control among women with type 1 diabetes and the role of MiniMed 780G system: A narrative review
by: Isabeau Thijs, et al.
Published: (2026)

Obesity and overweight‐related differences in cardiometabolic risk factors in type 1 diabetes
by: Adnan S. Syed, et al.
Published: (2025)

Real‐world evaluation of teplizumab in type 1 diabetes: Progression to insulin requirement
by: Sahana Mahesh, et al.
Published: (2025)

Association of time in tight range and 1,5‐anhydroglucitol in type 2 diabetes
by: Hang Su, et al.
Published: (2025)

The protective role of TIGIT + B cells in attenuating type 1 diabetes progression
by: Yiman Peng, et al.
Published: (2025)

Risk of diabetic retinopathy and ophthalmic interventions in patients with diabetes mellitus taking different oral anticoagulants
by: Hou‐Ren Tsai, et al.
Published: (2025)

Predictors of diabetic ketoacidosis in patients with insulin‐deficient diabetes phenotype initiating SGLT2 inhibitors
by: Anat Tsur, et al.
Published: (2025)

Association between time in tight range and incident diabetic retinopathy in adults with type 2 diabetes
by: Yaxin Wang, et al.
Published: (2024)

Glycaemic and weight effects of metabolic surgery or semaglutide in diabetes dosage for patients with type 2 diabetes
by: Erik Stenberg, et al.
Published: (2024)

Correction to “Defining diabetes status using medication groups in Medicare data: Trends in prescribing diabetes medications to patients without a diabetes diagnosis over time”
Published: (2024)